InvestorsHub Logo
Followers 85
Posts 1010
Boards Moderated 0
Alias Born 03/18/2013

Re: angelicsatan666 post# 129331

Friday, 04/18/2014 8:59:12 AM

Friday, April 18, 2014 8:59:12 AM

Post# of 158400
One only has to look at the timing of the issuing of the dividend to comprehend that BMSN most likely already has the approval to begin phase 1 for Hemaxellerate.

While they announced the dividend in October, at anytime they could have backed out and not followed through with the issuance. It's a lot of paperwork and time spent to issue a spin off, so a company would absolutely not do it unless they had some assurance that they are moving forward as planned.

Since their most recent estimate was to have approval for the FDA phase 1 trials no later than March 31st, BMSN indicated the official distribution date on March 6th tells me that they are ready to proceed.

Regardless of all that above, if the answers from the FDA were negative, they would have already had to report it.

BMSN being overvalued is just laughable and beneath you sir. BMSN is probably the most undervalued stock on the market right now caused by impatience and misinformed sellers swindled out of their shares by misinformation.

Go BMSN/Regen!! bsmiled

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.